TNFRSF17 and cancer: BCMA+ cell lines (MM1.S, RPMI-8226, and LP-1) were eradicated upon each rechallenge when co-cultured with either CT103a or nanoCAR, in contrast to the Mock group, which was incapable of killing all tumor cells or cancer cells incubated alone (Figure 3A,B).